BlessUp Peptide Library · Defense & Repair
LL-37 and KPV. Two peptides your body already makes, sold as a natural antibiotic and a natural anti-inflammatory.
Your body releases these with precision. A syringe does not, and for one of them that difference is where the danger lives.
LL-37 is a real host-defense and wound-healing peptide, and also a documented driver of psoriasis. KPV calms inflammation in cells and mice, with no human trials of any kind. Full citations at the end.
You have seen them sold as the body's own medicine: LL-37 as a natural antibiotic that kills anything and heals wounds, KPV as a clean anti-inflammatory that calms your gut and skin without steroids.
Here is the honest version. Both of these are real molecules your body already makes, and the underlying biology is genuinely elegant. LL-37 is your only human cathelicidin, a defense peptide that physically punctures microbes and helps close wounds. KPV is the tiny business-end of a hormone called alpha-MSH, and it quiets inflammation at the source. But the marketing runs far ahead of the proof. The human evidence for LL-37 is almost all local (put on or into a wound), not the systemic injections people actually do, and KPV has never been tested in a human at all, only in cells and mice. And LL-37 carries a genuine twist: the same peptide that defends you can, at the wrong dose, turn on you and drive autoimmune inflammation. So the useful thing we can do is line each one up against what it actually does and the proof it actually has. We do honest, not hype.
Read this first
This is education, not medical advice, and it does not replace your own clinician. Neither of these is FDA-approved, and neither has large human trials for the injected use people do; KPV has no human trials of any kind. Neither is a substitute for real treatment: a serious infection needs a doctor and antibiotics, and inflammatory bowel disease needs a specialist. Any dose named here is an example for discussion, never a prescription.
90-second self-check
This flags the real hard stops, and if you are clear, points toward the compound that matches your goal. It is education, not a diagnosis or a recommendation to use anything.
Answer honestly. Nothing is stored, and no one sees it but you.
First, the hard stops. Do any of these apply to you? (tap all that are true)
What are you actually weighing this class for?
Any of these in your picture? (tap all that apply)
Is this replacing something it should not? (tap all that apply)
This reflection is education only, not a diagnosis or a recommendation to use any compound. Talk to a licensed provider about your own history and goals.
The basics
This is a genuinely small class, just two peptides, and both are copies of molecules your own body makes as part of its defense system. They do two different jobs:
| Compound | What it does | Studied for | Evidence level | Route |
|---|---|---|---|---|
| LL-37 | Host defense: punctures microbes, heals wounds, calls in immune cells | Infection, chronic wounds, biofilm | Strong lab + human tissue (local); no systemic trials | Topical / SubQ |
| KPV | Anti-inflammatory: switches off NF-kB, quiets the gut and skin | Gut inflammation (IBD), skin, wounds | Cells and mice only; no human trials of any kind | Oral / topical / SubQ |
A note on the neighbors: "anti-inflammatory peptide" gets used loosely. The tissue-repair peptides in our BPC-157 and TB-500 guides, and the immune modulators in the immune and thymic guide, are separate classes. This report is specifically about the two host-defense peptides above.
The honest half-truth you will hear
"It is natural, so it is safe, and it works like your body intended." Two problems. Your body releases these in tiny amounts, in the right place, at the right moment, LL-37 locally at a wound, KPV through a gut transporter. Injecting a steady systemic dose is a different thing entirely, and that is exactly the version with almost no human evidence. And "natural" does not mean gentle: LL-37 at higher or chronic doses becomes cytotoxic and pro-inflammatory, and can drive real autoimmune disease.
The part the marketing flattens
They are sold as if the science were settled. It is not, and honestly this is one of the thinnest-evidenced classes we cover. Here is an honest read of how much real human evidence sits behind each. Longer bars mean deeper human data, not "works better," and both bars are short.
Depth of human evidence, by compound
Even the taller bar is local, human-tissue wound data, not the systemic injections people do. KPV has no human data at all.
LL-37: Heilborn 2003 (essential for human wound re-epithelialization, deficient in chronic ulcers). KPV: Dalmasso 2008 (reduces colitis in mice via a gut transporter). The systemic injected use has no supporting trials for either. Full citations below.
Read the shape honestly. LL-37 has real human-tissue evidence, but it is about the peptide acting locally in a wound, not a systemic injection, and it comes with a documented dark side. KPV has a coherent story in animals that has simply never been tested in a person. If you are drawn to this class, you are betting on mechanism, not results.
Under the hood
Its positive charge pulls it to a microbe's membrane, where it inserts and tears open a pore. It works on bacteria, fungi, and some viruses, and even breaks up biofilms, and because it targets a basic feature of membranes, resistance is hard to evolve.
KPV blocks NF-kB, the switch that turns on inflammatory genes, lowering signals like IL-6 and TNF at the source. A gut transporter that ramps up in inflamed tissue helps carry it in, which is why the animal data is strongest in the gut.
LL-37 is dose-dependent: low and local, it defends and heals; high or chronic, it turns cytotoxic and pro-inflammatory, and can act as a self-antigen that drives psoriasis and lupus. KPV's whole story, meanwhile, is still preclinical. Your body's exact dose and timing are the point; a syringe cannot reproduce them.
That last panel is the whole reason for caution. These are not simple "more is better" molecules. The dose and the location are what separate a defender from a driver of disease, and that precision is exactly what an injection gives up.
The two, with honest pros and cons
A small class, and honestly an under-proven one. Tags show the standing: host-defense and anti-inflammatory, both still short on human proof.
Your only human cathelicidin: a defense peptide that punctures microbes, closes wounds, and rallies the immune system. Real and central biology, with a real dark side.
Honest read: a real defense peptide whose safe zone is low and local; systemic use is unproven and the autoimmune risk is genuine. Studied mostly topically or into a wound.
The tiny active fragment of alpha-MSH that quiets inflammation by switching off NF-kB. A clean, targeted idea, with the human proof entirely missing.
Honest read: a promising preclinical idea that has completely outrun its evidence. Interesting to watch, not a proven tool, and never a substitute for real care. Studied orally and topically in animals.
The line that matters most
The single most important idea in this class is that your body already makes both of these, and it does so with a precision no injection can match. LL-37 is released locally, right where a wound or infection is, in a controlled burst, then cleared. KPV rides a transporter that is most active exactly in inflamed tissue. That targeting is the whole design. Flooding your bloodstream with a steady dose of an injected copy is not "supporting" that system, it is overriding it, and for LL-37 that is precisely where the safe defender becomes a driver of inflammation.
Two things to hold onto
First, this is an unusually thin-evidenced class: LL-37's human data is local wound tissue, and KPV has no human data at all, so both are bets on mechanism. Second, LL-37's double edge is real and dose-dependent, which makes an autoimmune or inflammatory condition a genuine caution, not a footnote. Neither of these is a substitute for treating an actual infection or an actual inflammatory disease.
The most important section here
These come straight from the mechanisms. A few situations are genuinely off-limits or need a provider.
This is the sharpest line, and it belongs to LL-37. It is a documented self-antigen in psoriasis, rosacea, and lupus, meaning it can feed the exact autoimmune loop it is supposed to help. If you have any autoimmune or inflammatory condition, this is a stop-and-ask-a-specialist situation, not a self-experiment.
Neither peptide has human safety data in pregnancy or breastfeeding. Do not use if you are pregnant, breastfeeding, or trying to conceive. Clear it first.
These are immune-active, growth-adjacent peptides with thin safety data. Adding one into an active-cancer picture, or before you have a diagnosis on something concerning, is the wrong move. This belongs to an oncologist, not a self-directed trial.
LL-37 works by activating your immune system, which is directly opposed to what those medications are doing. That is a real conflict, and KPV's interactions are simply unstudied. Loop in the prescriber before anything.
A serious infection needs a clinician and antibiotics; inflammatory bowel disease needs a gastroenterologist. Neither peptide is a proven substitute, and using an unproven peptide instead of treating a real infection is genuinely dangerous. Both are also research compounds with sourcing and sterility risk, and are prohibited in tested sport.
The one rule under all of it
If you have an autoimmune or inflammatory condition, LL-37 in particular is not a self-directed project, full stop. And if you have a real infection or a real inflammatory disease, the answer is proper treatment, not a peptide your body already makes in the right place at the right dose. Build the foundation below first.
Put it together
First question
Second question
The move most people skip
Ask what you are actually trying to fix, and whether it has a name and a real treatment. An infection, a wound that will not heal, an inflamed gut, these deserve a diagnosis and proven care first. These peptides are, at best, an unproven support on top of that, with real cautions of their own. Match the tool to a real, diagnosed need. Matching beats maxing.
The foundation under everything
Here is the part no peptide vendor mentions: your body already runs LL-37 and the whole anti-inflammatory system, for free, and the biggest lever is keeping that system healthy. These habits do more than an injected copy of a peptide you already make.
Your innate immune defenses, including your own cathelicidin, run best on real sleep, and smoking directly damages the barrier tissues (skin, lung, gut) where these peptides do their work. These are the highest-leverage moves, and they are free.
Vitamin D is a direct on-switch for your body's own LL-37 production, and a whole-food, protein-adequate diet keeps your barriers and immune cells supplied. Correcting a real deficiency does more than any injected peptide.
For chronic inflammation, the proven levers are diet, fiber, movement, sleep, and stress management, plus actually treating the underlying condition. That is where KPV's whole premise (calming NF-kB) is genuinely, reliably achieved.
The most powerful "antimicrobial" is the right antibiotic for a real infection, and the most powerful anti-inflammatory is proper care for a diagnosed disease. Neither peptide replaces getting the actual problem looked at.
Cutting through the noise
Proper care for a real infection or inflammatory disease, on a foundation that keeps your own defense peptides working. This does more than an injected copy of either compound.
The local, topical use is where LL-37's actual human-tissue evidence lives. And the lifestyle levers reliably achieve what KPV only proposes. Sensible, evidence-aligned support.
No systemic human trials for LL-37, and none of any kind for KPV. Curiosity at your own risk, not confidence, and not a substitute for care.
The exact situations where these peptides' mechanisms push the wrong way, or where delaying real care does harm. A specialist decision, never a self-directed one.
Turn this into action
Have I honestly ruled out the hard stops: any autoimmune or inflammatory condition, and pregnancy?
Does the thing I am trying to fix have a name and a real, proven treatment I should get first?
Am I clear that LL-37's evidence is local and topical, and that KPV has no human data at all?
Am I at risk of using this instead of getting an actual infection, wound, or disease properly treated?
Is a knowledgeable provider genuinely involved?
Bring these to your visit
Given my history, especially any autoimmune or skin condition, is LL-37 safe for me to even consider?
Is what I am dealing with actually an infection or an inflammatory disease that needs real treatment first?
Given there are no human trials of injecting these, what realistic result should I expect?
If I am on an immunosuppressant or a biologic, does LL-37 work against my treatment?
A few situations are not "go slower," they are "stop and be seen."
A mild injection-site reaction settles. A spreading infection or an autoimmune flare does not wait, and treating a real infection with an unproven peptide instead of care is dangerous. When in doubt, be seen.
The BlessUp take
The idea here is genuinely beautiful: your body already makes its own antibiotic and its own anti-inflammatory, LL-37 to punch through microbes and close wounds, KPV to quiet inflammation at its source. The biology is real and, in the lab, impressive. But the honest human story is thin, and for one member it is a double-edged sword. LL-37's actual human evidence is local, in a wound, not the systemic shots people take, and at the wrong dose it flips from defender to a driver of psoriasis and lupus. KPV has never been tested in a single human at all. So this is a class where the mechanism is elegant and the proof is mostly a promise. The most powerful version of what these peptides do is the one your own body already runs, for free, when you sleep, keep your vitamin D up, do not smoke, and actually treat the infection or the inflammatory disease that is really there. If you still have a real, diagnosed reason to explore this class, go in knowing the human proof is thin to absent, respect LL-37's double edge, never let it replace real care, and do it with a provider. That is not the timid move. It is the one that respects how precisely your body already does this.
The evidence
Retrieved from PubMed. LL-37's real evidence is host-tissue defense and wound healing (shown here), balanced against its documented role in driving autoimmune inflammation; KPV's evidence is preclinical only. None of these tested the systemic injected use people do.
Citations retrieved from PubMed. LL-37's human evidence is local and tissue-level (wound healing), and it is separately a documented driver of psoriasis autoimmunity, the double edge. KPV's evidence is entirely preclinical (cells and mouse colitis), with no human administration trial of any kind. This report is an honest educational map of the class, not a dosing sheet or a recommendation to use any compound.